Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2018
Event Date: January 5, 2018 (Effective date of agreement)
Context: The Company, an emerging growth company, entered into a material definitive agreement to amend and restate its existing debt facilities with Squadron Capital LLC.
Key Financial Metrics and Debt Structure
This filing details a refinancing of the Company's debt obligations rather than reporting operational financial performance (revenue, profit, or cash flow).
- Term Loan Principal: $20.0 million (consolidated from prior notes).
- Revolving Loan Facility: Up to $15.0 million.
- Interest Rate (Applicable Rate): The lesser of (a) 3-month LIBOR + 8.61% or (b) 10.0%.
- Previous Interest Rates: 10.0% for the term note and 11.0% for the revolving facility.
- Maturity Date: January 31, 2023 (subject to acceleration upon change of control).
- Collateral: Loans are secured by a security interest in the Company's and other Borrowers' assets.
Material Changes Versus Prior Period
The Fourth Amended and Restated Loan and Security Agreement modifies the Third Amended and Restated Loan and Security Agreement dated April 26, 2017, in the following ways:
- Consolidation: Prior term note amounts were consolidated into a single $20.0 million term note, and the $15.0 million revolving loan was reestablished.
- Interest Rate Reduction: The interest rate structure was changed to the "Applicable Rate" (LIBOR + 8.61% capped at 10.0%), reducing the fixed rate previously applied to the revolving credit facility (11.0%).
- Extension of Maturity: The loan period was extended to January 31, 2023, compared to the previous maturity dates of May 31, 2019, or 2020 (which were contingent on revenue).
Management Commentary, Risks, and Contingencies
Lender Influence: Squadron Capital LLC holds greater than 5% of the Company's common stock and has designated four directors to the Company's Board of Directors pursuant to a separate Stockholders' Agreement.
Events of Default: The agreement includes customary events of default. If an event of default is not cured within specified time periods, the Lender has the right to accelerate payment of principal and interest.
Change of Control: Principal and accrued interest become due immediately upon the earlier of the maturity date or a transaction where a person or entity acquires a majority of voting power or substantially all assets.
Financial Performance: The filing text does not provide clear values for revenue, profit, cash flow, or liquidity metrics for the reporting period.
Investor Verification Checklist
- Verify the exact amount of principal outstanding under the new $20.0 million term note and the utilization of the $15.0 million revolving facility.
- Confirm the current 3-month LIBOR rate to calculate the actual effective interest rate under the new "Applicable Rate" formula.
- Review the specific covenants and "customary events of default" detailed in the attached Exhibits 10.1, 10.2, and 10.3.
- Assess the impact of the Lender's four board seats on corporate governance and strategic direction.
- Monitor the Company's ability to meet the January 31, 2023, maturity date or potential refinancing needs prior to that date.